Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered sertonin transmission

Brain Research

Volumn 732, Issue 1-2, 1996, Pages 25-35

  Walker, Paul D ^a   Capodilupo, John G ^a   Wolf, William A ^b,c   Carlock, Leon R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

5 HT(1A) receptor; 5 HT2 receptor; basal ganglia; opioid; p chlorophenylalanine; substance P; tachykinin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5,7 DIHYDROXYTRYPTAMINE; FENCLONINE; MESSENGER RNA; PREPROENKEPHALIN; PREPROTACHYKININ; RECEPTOR SUBTYPE; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

EID: 0030565579     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00483-0     Document Type: Article

References (73)

1. Abood M.E., Eberwine J.H., Erdelyi E., Evans C.J. Regulation of both preproenkephalin mRNA and its derived opioids by haloperidol - a method for measurement of peptides and mRNA in the same tissue extract. Mol. Brain Res. 8:1990;243-248.
2. 1A receptor gene. J. Biol. Chem. 265:1990;5825-5832.
3. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience. 27:1988;1-39.
4. 125I]LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region. Brain Res. 372:1986;130-136.
5. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1994;1-28.
6. 2 receptors of the rat. Neuropharmacology. 31:1992;1-8.
7. Auerbach S.B., Minzenberg M.J., Wilkinson L.O. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499:1989;281-290.
8. Bannon M.J., Lee J.-M., Giraud P., Young A., Affolter H.-U., Bonner T. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. J. Biol. Chem. 261:1986;6640-6642.
9. Bannon M.J., Elliot P.J., Bunney E.B. Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists. Mol. Brain Res. 3:1987;31-37.
10. Bannon M.J., Kelland M., Chiodo L.A. Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum. J. Neurochem. 52:1989;859-862.
11. Barden N., Daigle M., Picard V., DiPaolo T. Perturbation of rat brain serotonergic systems results in an inverse relation between substance P and serotonin concentrations measured in discrete nuclei. J. Neurochem. 41:1983;834-840.
12. Becquet D., Faudon M., Hery F. The role of serotonin release and autoreceptors in the dorsalis raphe nucleus in the control of serotonin release in the cat caudate nucleus. Neuroscience. 39:1990;639-647.
13. Bendotti C., Tarizzo G., Fumagalli F., Baldessari S., Samanin R. Increased expression of preproneuropeptide Y and preprosomatostatin mRNA in striatum after selective serotoninergic lesions in rats. Neurosci. Lett. 160:1993;197-200.
14. 1A receptor agonists. J. Cardiovasc. Pharmacol. 15:1990;S42-S48.
15. 2 agonist. J. Neurochem. 56:1991;428-435.
16. 1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 561:1991;51-60.
17. Chaput Y., Araneda R.C., Andrade R. Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus. Eur. J. Pharmacol. 182:1990;441-456.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
19. Dellavedova L., Parenti M., Tirone F., Groppetti A. Interactions between serotonergic and enkephalinergic neurons in rat striatum and hypothalamus. Eur. J. Pharmacol. 85:1982;29-34.
20. 3H]-5-HT from slices of rat globus pallidus. Biochem. Pharmacol. 36:1987;1738-1740.
21. 1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci. Lett. 118:1990;189-192.
22. Gerfen C.R., Young W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
23. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
24. Gerfen C.R., McGinty J.F., Young W.S. III Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
25. Haverstick D.M., Rubenstein A., Bannon M.J. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 248:1989;858-862.
26. Haverstick D.M., Bannon M.J. Evidence for dual mechanisms involved in methamphetamine-induced increases in striatal preprotachykinin mRNA. J. Biol. Chem. 264:1989;13140-13144.
27. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48:1991;1779-1786.
28. Hong J.-S., Yang H.-Y.T., Costa E. Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs. Neuropharmacology. 17:1978;83-85.
29. Hong J.-S., Yang H.-Y.T., Fratta W., Costa E. Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. J. Pharmacol. Exp. Ther. 205:1978;141-147.
30. Hong J.-S., Yoshikawa K., Kanamatsu T., Sabol S.L. Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Fed. Proc. 44:1985;2535-2539.
31. Koe B.K., Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154:1966;499-516.
32. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. USA. 84:1987;881-885.
33. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269:1994;1268-1279.
34. Lam D.M., Su Y.T., Watt C.B. The self-regulating synapse: a functional role for the co-existence of neuroactive substances. Brain Res. Rev. 11:1986;249-257.
35. 1A receptor agonist 8-OH-DPAT. Neuropharmacology. 29:1990;85-91.
36. Lavoie B., Parent A. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the Squirrel monkey. J. Comp. Neurol. 299:1990;1-16.
37. 2/1C receptor activation causes a localized expression of immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibers. Neuroscience. 53:1993;457-463.
38. Li S., Jiang H.K., Stachowiak M.S., Hudson P.M., Owyang V., Nanry K., Tilson H.A., Hong J.S. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Mol. Brain Res. 8:1990;219-225.
39. 1A receptors: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem. Int. 19:1991;453-465.
40. Mocchetti I., Giorgi O., Schwartz J.P., Costa E. A reduction of the tone of 5-hydroxytryptamine neurons decreases utilization rates of striatal and hypothalamic enkephalins. Eur. J. Pharmacol. 106:1985;427-430.
41. Mocchetti I., Schwartz J.P., Costa E. Use of mRNA hybridization and radioimmunoassay to study mechanisms of drug-induced accumulation of enkephalins in rat brain structures. Mol. Pharmacol. 28:1985;86-91.
42. Morris B.J., Reimer S., Herz A. Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Mol. Brain Res. 4:1988;15-22.
43. Normand E., Popovici T., Onteniente B., Fellman D., Piatier-Tonneau, Auffray C., Bloch B. Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Brain Res. 439:1988;39-46.
44. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
45. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors Brain Res. 346:1985;205-230.
46. Pazos A., Cortes R., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors Brain Res. 346:1985;231-249.
47. Penny G.R., Afsharpour S., Kitai S.T. The glutamate decarboxylase, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap. Neuroscience. 17:1986;1011-1045.
48. 2 dopamine receptors. Mol. Brain Res. 12:1992;111-119.
49. 2C receptors. Mol. Brain Res. 23:1994;163-178.
50. 2 receptor. EMBO J. 7:1988;4135-4140.
51. Reimer S., Sirinathsinghji D.J., Nikolorakis K.E., Holt V. Differential dopaminergic regulation of proenkephalin and prodynorphin mRNAs in the basal ganglia of rats. Mol. Brain Res. 12:1992;259-266.
52. Reiner A., Anderson K.D. The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res. Rev. 15:1990;251-265.
53. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96:1989;283-290.
54. Siever L.J., Kahn R.S., Lawlor B.A., Trestman R.L., Lawrence T.L., Coccaro E.F. Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol. Rev. 43:1991;509-525.
55. Sivam S.P., Breese G.R., Krause J.E., Napier T.C., Mueller R.A., Hong J.-S. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J. Neurochem. 49:1987;1623-1633.
56. Sivam S.P., Krause J.E. The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion. Brain Res. 536:1990;169-175.
57. Sivam S.P., Krause J.E. Compensatory activation of substance P biosynthesis by 1-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats. J. Pharmacol. Exp. Ther. 254:1990;433-439.
58. Sivam S.P., Krause J.E., Breese G.R., Hong J.-S. Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia. J. Neurochem. 56:1991;1499-1508.
59. Sivam S.P. Serotonergic regulation of striatal dynorphin and substance P systems: a study with serotonin uptake inhibitor fluoxetine. Neurosci. Res. Commun. 17:1995;209-215.
60. Soghomonian J.-J., Descarries L., Watkins K.C. Serotonin innervation in adult rat neostriatum. II. Ultrastructural features: a radioautographic and immunocytochemical study Brain Res. 481:1989;67-86.
61. 1A selective agonists. Eur. J. Pharmacol. 128:1986;295-298.
62. 1B agonists. Synapse. 1:1987;3-9.
63. Steinbusch H.W.M. Distribution of serotonin-immunoreactivity in the central nervous system of the rat. Cell bodies and terminals. Neuroscience. 6:1981;557-618.
64. Stoetter, B., Braun, A.R., Randolph, C., Gernet, J., Carson, R.E., Herscovitch, P. and Chase, T.N., Functional neuroanatomy of Tourette syndrome: limbic-motor interactions studied with FDG PET, In T.N. Chase, A.J. Friedhoff and D.J. Cohen (Eds.), Advances in Neurology, Vol. 58, Raven Press, NY, 1992, pp. 213-227.
65. Vandermaelen C.P., Matheson G.K., Wilderman R.C., Patterson L.A. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmacol. 129:1986;123-130.
66. Vernier P., Julien J.-F., Rataboul P., Fourrier O., Feuerstein C., Mallet J. Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. J. Neurochem. 51:1988;1375-1380.
67. Walker P.D., Riley L.A., Hart R.P., Jonakait G.M. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum. Brain Res. 546:1991;33-39.
68. Walker P.D., Riley L.A., Hart R.P., Jonakait G.M. Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions. Brain Res. 557:1991;31-36.
69. Wang H.-Y., Friedman E. Central 5-hydroxytryptamine receptor-linked protein kinase C translocation: a functional postsynaptic signal transduction system. Mol. Pharmacol. 37:1990;75-79.
70. Widmann R., Sperk G. Topographical distribution of amines and major amine metabolites in the rat striatum. Brain Res. 367:1986;244-249.
71. Wolf W.A., Bobik A. alpha-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release. Eur. J. Pharmacol. 163:1989;43-53.
72. Yoshikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA: cDNA cloning, primary structure and distribution in the central nervous system. J. Biol. Chem. 259:1984;14301-14308.
73. Young W.S. III, Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA. 83:1986;9827-9831.